Roland Kappler

Dr. Von Hauner Children's Hospital, Lindwurmstreet 2a
Munich, BY 80337, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

Journal: International journal of molecular sciences
Published: April 17, 2026

Proteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma.

Proteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma.

Journal: Cells
Published: March 25, 2026

Does Chemotherapy Have an Effect on the Treatment Success of Children and Adolescents with Unresectable Hepatocellular Carcinoma? Findings from the German Liver Tumour Registry.

Does Chemotherapy Have an Effect on the Treatment Success of Children and Adolescents with Unresectable Hepatocellular Carcinoma? Findings from the German Liver Tumour Registry.

Journal: Cancers
Published: July 02, 2025

Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumors.

Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumors.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 28, 2025

Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma.

Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma.

Journal: Cancers
Published: March 20, 2025

Mimicking cancer therapy in an agent-based model: The case of hepatoblastoma.

Mimicking cancer therapy in an agent-based model: The case of hepatoblastoma.

Journal: Computer methods and programs in biomedicine
Published: March 18, 2025

Multiancestry Transcriptome-Wide Association Study Identifies Candidate Genes Associated with Hepatoblastoma.

Multiancestry Transcriptome-Wide Association Study Identifies Candidate Genes Associated with Hepatoblastoma.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: October 22, 2024

Identification of a Growth-Promoting Gene Cluster in the Region 2q24 as a Driver of Tumorigenesis in Childhood Hepatoblastoma.

Identification of a Growth-Promoting Gene Cluster in the Region 2q24 as a Driver of Tumorigenesis in Childhood Hepatoblastoma.

Journal: The American journal of pathology
Published: October 13, 2024

Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma.

Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 28, 2024

Hepatoblastoma Relapse-Findings from the German HB99 Trial and the German Liver Tumor Registry.

Hepatoblastoma Relapse-Findings from the German HB99 Trial and the German Liver Tumor Registry.

Journal: Cancers
Published: November 09, 2023

Impact of BCL-2 Expression on Course of Disease in Neuroblastoma.

Impact of BCL-2 Expression on Course of Disease in Neuroblastoma.

Journal: European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
Published: September 29, 2023

Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.

Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.

Journal: Hepatology communications
Published: September 07, 2023
Showing 1-12 of 62

Last Updated: 09/26/2026